Yohimbine disrupts prepulse inhibition in rats via action at 5-HT 1A receptors, not α2-adrenoceptors

Psychopharmacology

Volumn 180, Issue 3, 2005, Pages 491-500

  Powell, Susan B ^a   Palomo, Javier ^a   Carasso, Barbara S ^a   Bakshi, Vaishali P ^b   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Atipamezole; Clonidine; Guanfacine; Medetomidine; Noradrenergic; Norepinephrine; Prazosin; Sensorimotor gating; Serotonin; WAY100,635

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; CLONIDINE; GUANFACINE; MEDETOMIDINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PRAZOSIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GUANFACINE; IMIDAZOLES; INJECTIONS; MALE; MEDETOMIDINE; NEURAL INHIBITION; PIPERAZINES; PRAZOSIN; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN ANTAGONISTS; STARTLE REACTION; YOHIMBINE;

EID: 21344455356     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-2193-7     Document Type: Article

References (33)

1. Abercrombie ED, Keller RW, Zigmond MJ (1988) Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 27:897-904
2. 1A receptors. Biochem Pharmacol 45(11):2337-2341
3. 1 noradrenergic antagonist. J Pharmacol Exp Ther 283:666-674
4. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
5. Ballmaier M, Zoli M, Mazzoncini R, Gennarelli M, Spano F (2001) Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle. Psychopharmacology 159(1):105-110
6. Blake TJ, Tillery CE, Reynolds GP (1998) Antipsychotic drug affinities at alpha 2-adrenoceptor subtypes in post-mortem human brain. J Psychopharmacol 12(2):151-154
7. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234-258
8. 1 adrenoceptor stimulation in rats. Neuropharmacology 37(3):401-404
9. Cheng CH, Costall B, Ge J, Naylor RJ (1993) The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats. Br J Pharmacol 110(3):1079-1084
10. Davis M (1988) Apomorphine, D-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex. Psychopharmacology 95:151-156
11. Davis M, Astrachan DI (1981) Spinal modulation of acoustic startle: opposite effects of clonidine and D-amphetamine. Psychopharmacology 75:219-225
12. Davis M, Mansbach RS, Swerdlow NR, Campeau S, Braff DL, Geyer MA (1990) Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology 102:1-4
13. Friedman JI, Adler DN, Temporini HD, Kemether E, Harvey PD, White L, Parrella M, Davis KL (2001) Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology 25(3):402-409
14. Geyer MA, Swerdlow NR (1999) Multiple transmitters modulate prepulse inhibition of startle: relevance to schizophrenia. In: Palomo T, Beninger RJ, Archer T (eds) Interactive monoaminergic disorders. Fundacion Cerebro y Mente, Editorial Sintesis S.A. Madrid, pp 343-354
15. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485-498
16. Geyer, MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117-154
17. Graham FK (1975) The more or less startling effects of weak prestimuli. Psychophysiology 12:238-248
18. 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Naunyn Schmiedebergs Arch Pharmacol 356:570-582
19. 2 adrenoceptor blockade. Science 286:105-107
20. 1A receptor agonism. Brain Res 956(2):349-357
21. Kehne JH, Davis M (1985) Central noradrenergic involvement in yohimbine excitation of acoustic startle: effects of DSP4 and 6-OHDA. Brain Res 330:31-41
22. Kehne JH, Padich RA, McCloskey TC, Taylor VL, Schmidt CJ (1996) 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats. Psychopharmacology 124:95-106
23. 2 adrenoceptors are important modulators of the effects of Damphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29:1282-1293
24. Ludewig S, Ludewig K, Geyer MA, Hell D, Vollenweider FX (2002) Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety 15:55-60
25. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507-514
26. 3 receptors. Significance for the modulation of fronto-cortical monoaminergic transmission and depressive states. Synapse 35:79-95
27. 1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 358(2):197-206
28. Pudovkina OL, Kawahara Y, de Vries J, Westerink BH (2001) The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis. Brain Res 906:38-45
29. Rigdon GC, Weatherspoon JK (1992) 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263:486-493
30. Sipes TA, Geyer MA (1995) 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology 117(1):41-48
31. Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156:194-215
32. Varty GB, Bakshi VP, Geyer MA (1999) M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 20:311-321
33. Winter JC, Rabin RA (1992) Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J Pharmacol Exp Ther 263:682-689